Investor Update

Basel, 25 February 2021

Invitation to the Roche Diagnostics Investor Day 2021: Innovating diagnostics, shaping healthcare, changing lives



We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 23 March 2021 highlighting future growth drivers of the Division.
We will welcome you to the event in our new virtual 360° platform which will be accessible one day prior to the event (as of 15:00 CET). We would like to invite you to visit our virtual marketplace and participate in a self-guided virtual showroom tour. Stay tuned!

14:00-16:00 CET / 13:00-15:00 GMT
9:00-11:00am EDT / 6:00-8:00am PDT


The event will address the following topics:

  • Diagnostics market opportunities, strategy and organisation
  • Overview on R&D and new technologies
  • Late stage pipeline: Systems and diagnostics solutions for selected disease areas such as infectious diseases, cardiology and oncology


Speakers will include:

  • Thomas Schinecker, CEO Roche Diagnostics

  • Ann Costello, Global Head Roche Diagnostics Solutions

  • Palani Kumaresan, Global Head of Research & Development

  • Benjamin Lilienfeld, Life Cycle Leader Serum Work Area Systems

  • Michael Hombach, Global Clinical Leader Infectious Diseases

  • Andre Ziegler, Global Clinical Leader Cardiology

  • Jill German, Global Head of Pathology Lab


The webinar will start with presentations, followed by a Q&A session (live access to the speakers).

Access to virtual event (pre-registration required):
Please pre-register for our webinar here until 15 March 2021.

A replay of the event will be available via > ir.roche.com

*privacy notice

Best regards,

Karl Mahler
Head of Investor Relations and
Roche Group Planning

Birgit Masjost
Investor Relations Officer
 
Roche Investor Relations
Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com
 
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com
 
Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com
 
Investor Relations North America
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com